Company News
18 Oct
Spectris completes acquisition of Omnicon
Spectris has completed the acquisition of privately-held US company The Omnicon Group, for an initial consideration of $29m.
18 Oct
AstraZeneca granted priority review from FDA for Lynparza in metastatic breast cancer
AstraZeneca said on Wednesday that it and Merck & Co have been granted priority review by the US Food and Drug Administration for a supplemental new drug application for the use of Lynparza (olaparib) tablets in patients with metastatic breast cancer who have been previously treated with chemotherapy.